1. Abeloff's Clinical Oncology. (2008) Authors: Niederhuber, John E; Armitage, James O; Doroshow, James H; Kastan, Michael B; Tepper, Joel E Record Type: Book Extent: 1 online resource (2208 pages) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Abeloff. Oncología clínica. (2020) Editors: Niederhuber, John E; Armitage, James O; Doroshow, James H; Kastan, Michael B; Tepper, Joel E Record Type: Book Extent: 1 online resource (2072 pages) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biosimilar and generic cancer drugs unlikely to bend cost curve in the USA. Issue 1 (January 2017) Authors: Bennett, Charles L; Sartor, Oliver A; Armitage, James O; Kantarjian, Hagop Journal: Lancet oncology Issue: Volume 18:Issue 1(2017:Jan.) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Generic drugs in oncology – Authors' reply. Issue 2 (February 2017) Authors: Bennett, Charles L; Nagai, Sumimasa; Yang, Y Tony; Chen, Brian K; Sartor, Oliver; Armitage, James O Journal: Lancet oncology Issue: Volume 18:Issue 2(2017:Feb.) Page Start: e64 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Generic oncology drugs: are they all safe?. Issue 11 (November 2016) Authors: Yang, Y Tony; Nagai, Sumimasa; Chen, Brian K; Qureshi, Zaina P; Lebby, Akida A; Kessler, Samuel; Georgantopoulos, Peter; Raisch, Dennis W; Sartor, Oliver; Hermanson, Terhi; Kane, Robert C; Hrushesky, William J; Riente, Joshua J; Norris, LeAnn B; Bobolts, Laura R; Armitage, James O; Bennett, Charl... Journal: Lancet oncology Issue: Volume 17:Issue 11(2016:Nov.) Page Start: e493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Leukemic transformation in patients with myeloproliferative neoplasms: a population-based retrospective study. (June 2017) Authors: Shrestha, Rajesh; Giri, Smith; Armitage, James O; Bhatt, Vijaya Raj Journal: Future oncology Issue: Volume 13:Number 14(2017) Page Start: 1239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Non-Hodgkin lymphoma. Issue 10091 (15th July 2017) Authors: Armitage, James O; Gascoyne, Randy D; Lunning, Matthew A; Cavalli, Franco Journal: Lancet Issue: Volume 390:Issue 10091(2017) Page Start: 298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions. Issue 8 (August 2021) Authors: Bennett, Charles L; Focosi, Daniele; Socal, Mariana P; Bian, Julia C; Nabhan, Chadi; Hrushesky, William J; Bennett, Andrew C; Schoen, Martin W; Berger, Joseph R; Armitage, James O Journal: Lancet Issue: Volume 8:Issue 8(2021) Page Start: e593 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Role of molecularly-cloned hematopoietic growth factors after acute high-dose radiation exposures. (10th November 2021) Authors: Lazarus, Hillard M; Armitage, James O; Gale, Robert Peter Journal: Journal of radiological protection Issue: Volume 41:Number 4(2021) Page Start: S478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Secondary acute myeloid leukemia in survivors of Hodgkin lymphoma. (July 2016) Authors: Bhatt, Vijaya R; Giri, Smith; Verma, Vivek; Dahal, Sumit; Shah, Binay K; Pathak, Ranjan; Bociek, R Gregory; Vose, Julie M; Armitage, James O Journal: Future oncology Issue: Volume 12:Number 13(2016) Page Start: 1565 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗